Arch Therapeutics 10K 2022 Annual report | ARTH Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. junior Avg

New words: accretion, adjourn, admission, advocate, aka, ambient, analyze, antidilution, array, article, aseptically, attestation, basic, Biannual, bid, bifurcated, bill, billed, billing, biopharmaceutical, BMS, boutique, Canada, Canadian, cast, Catalog, cell, Cellanyx, Centurion, charity, cite, cited, CMS, Codification, condensed, confidence, consequential, convenient, covenant, creditor, CSE, DAPA, delisting, devitalized, diagnostic, die, died, disproportionate, divesting, divided, doctor, DOD, ECAT, eighteen, elapsed, Electronic, elevated, embedded, emotional, endovascular, entrepreneurial, Etiometry, exacerbated, exact, exorbitant, extracellular, feel, Fish, FitLife, Fletcher, float, floor, foreclose, foreclosure, fourth, freestanding, FSS, Fundamental, geopolitical, GSA, Guy, Han, harder, Harvard, headcount, hindrance, hundred, IHS, Indian, INO, insolvency, inspector, invoice, invoiced, irregularly, Ivy, judgement, lacerated, Lawrence, lifestyle, literature, lowest, matrix, meantime, Meshkin, Metabolon, mobility, multiplied, nationwide, nontraumatic, nutritional, NYSE, occupying, overburdened, parent, people, pharma, PhaseBio, phenomenon, phrase, plurality, premium, prepayment, problematic, prolonged, Qiu, ramp, remeasured, rental, return, Rice, RiseIT, roughly, salvage, save, shaped, shift, sixty, skye, Spaght, stagnant, Steiner, Stern, stimuli, subsection, systematic, tempering, temporary, tool, turnaround, Ukraine, unamortized, unavailability, unnecessary, unreasonably, unrelated, unresponsive, usefully, user, variously, Venture, visit, Washington, wax, weigh, Wisconsin, worse, YELL

Removed: acquirer, Admired, advisor, affiliated, afforded, AMAG, appointment, Ariat, attack, automobile, Avtar, Bard, Baxter, Biomedical, Brenna, Brexit, Brilinta, Brilique, Chiron, confirmed, converting, daily, de, declining, Diego, distributing, domestic, Donnelley, ensuring, Entrepreneur, Ernst, Esprit, finalist, focusing, globally, granting, immune, instability, integration, interested, Irrevocable, Johnson, Journal, labor, lawfully, Maxygen, MDD, Memory, Momenta, Nathaniel, nephew, offered, online, operationally, PharmaVoice, phase, pioneering, promulgated, proven, ratifying, replaced, represented, requisite, resubstitution, Richard, San, SE, spare, Stanford, stead, stimulate, substitution, Supervisory, therewith, thing, ticagrelor, Tolero, transition, TSXV, UDI, updated, Valneva, violation, virtue, wealth, Young

Arch Therapeutics (ARTH) 10-K2022 FY Annual report

Content analysis